Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rafii

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Independent effects of white matter lesion volume and APOE ɛ4 on ARIA-H in A4 StudyZahra Shirzadi, Aaron P Schultz, Nazila Loghmani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2025
"Being brave, being seen, and having your voice heard": Perspectives of self-advocates and families toward accessible and impactful research of Alzheimer's disease in down syndromeSarah Walter, Lauren Ptomey, Elizabeth Head, et al.
JAMA Neurology|January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical TrialReisa Sperling, David Henley, Paul S Aisen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 25, 2021
Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trialJennifer Ngolab, Michael Donohue, Alison Belsha, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndromeAnna H Boerwinkle, Julie K Wisch, Benjamin L Handen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapseS Jain, J Cohen, M M Ward, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2024
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupClifford R Jack, J Scott Andrews, Thomas G Beach, et al.
Nature Medicine|June 28, 2024
Revised criteria for the diagnosis and staging of Alzheimer's diseaseClifford R Jack, Scott J Andrews, Thomas G Beach, et al.
JAMA Neurology|July 23, 2019
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical TrialChristopher H van Dyck, Haakon B Nygaard, Kewei Chen, et al.
Annals of Clinical and Translational Neurology|February 20, 2024
Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorderJonathan D Santoro, Mellad M Khoshnood, Saba Jafarpour, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Independent effects of white matter lesion volume and APOE ɛ4 on ARIA-H in A4 StudyZahra Shirzadi, Aaron P Schultz, Nazila Loghmani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2025
"Being brave, being seen, and having your voice heard": Perspectives of self-advocates and families toward accessible and impactful research of Alzheimer's disease in down syndromeSarah Walter, Lauren Ptomey, Elizabeth Head, et al.
JAMA Neurology|January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical TrialReisa Sperling, David Henley, Paul S Aisen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 25, 2021
Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trialJennifer Ngolab, Michael Donohue, Alison Belsha, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndromeAnna H Boerwinkle, Julie K Wisch, Benjamin L Handen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapseS Jain, J Cohen, M M Ward, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2024
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupClifford R Jack, J Scott Andrews, Thomas G Beach, et al.
Nature Medicine|June 28, 2024
Revised criteria for the diagnosis and staging of Alzheimer's diseaseClifford R Jack, Scott J Andrews, Thomas G Beach, et al.
JAMA Neurology|July 23, 2019
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical TrialChristopher H van Dyck, Haakon B Nygaard, Kewei Chen, et al.
Annals of Clinical and Translational Neurology|February 20, 2024
Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorderJonathan D Santoro, Mellad M Khoshnood, Saba Jafarpour, et al.
Pageof 22